Sears Capital Management logo

Sears Capital Management

North America, California, United States, Cupertino

Description

Sears Capital Management is a venture investment and portfolio management firm focused on the life sciences industry.

Investor Profile

Sears Capital Management has made 13 investments, with 0 in the past 12 months and 8% as lead.

Stage Focus

  • Series B (31%)
  • Series Unknown (31%)
  • Series C (8%)
  • Debt Financing (8%)
  • Series A (8%)
  • Series D (8%)
  • Seed (8%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Medical
  • Health Care
  • Health Diagnostics
  • Neuroscience
  • Pharmaceutical
  • Cosmetic Surgery
  • Manufacturing
  • Marketing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sears Capital Management frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 3
Mitsubishi International Corporation (MIC)
North America, Massachusetts, United States, Andover
Co-Investments: 2
BioBrit
North America, California, United States, La Jolla
Co-Investments: 3
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 2
Mission Bay Capital
North America, California, United States, San Francisco
Co-Investments: 2
NEXT Frontier Capital
North America, Montana, United States, Bozeman
Co-Investments: 2
Asset Management Company
North America, California, United States, Palo Alto
Co-Investments: 2
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Asset Management Ventures (AMV)
North America, California, United States, Palo Alto
Co-Investments: 3

Which angels does Sears Capital Management often collaborate with?

JZ
North America, Pennsylvania, United States, Philadelphia
Shared Deals: 1

What are some of recent deals done by Sears Capital Management?

AN2 Therapeutics

Menlo Park, California, United States

AN2 Therapeutics focuses on modern biomedical and drug development expertise to provide transformational medicines.

BiotechnologyHealth CarePharmaceutical
Series BJan 7, 2022
Amount Raised: $80,000,000
Coaxis Medical

San Mateo, California, United States

Coaxis Medical develops instruments and fixtures for tissue approximation and anastomosis in the minimally invasive surgical setting.

Health CareMedicalMedical Device
Series UnknownJan 1, 2018
Geom Therapeutics

San Francisco, California, United States

Geom Therapeutics is a biotechnology company.

BiotechnologyHealth CareTherapeutics
Series UnknownApr 8, 2017
Amount Raised: $4,355,000
SiteOne Therapeutics

Bozeman, Montana, United States

SiteOne Therapeutics is a San Francisco-based company that develops novel therapeutics and diagnostics.

BiotechnologyHealth DiagnosticsMedicalTherapeutics
Series BJan 6, 2017
Amount Raised: $15,000,000
SiteOne Therapeutics

Bozeman, Montana, United States

SiteOne Therapeutics is a San Francisco-based company that develops novel therapeutics and diagnostics.

BiotechnologyHealth DiagnosticsMedicalTherapeutics
Series UnknownJul 15, 2015
Amount Raised: $1,278,358
SiteOne Therapeutics

Bozeman, Montana, United States

SiteOne Therapeutics is a San Francisco-based company that develops novel therapeutics and diagnostics.

BiotechnologyHealth DiagnosticsMedicalTherapeutics
Series ASep 24, 2014
Amount Raised: $1,500,000
CharlestonPharma,LLC

Charleston, South Carolina, United States

CharlestonPharma is focused on developing innovative therapeutic antibodies and related diagnostic tests for cancer patients.

BiotechnologyHealth DiagnosticsMedicalTherapeutics
SeedJan 29, 2013
Amount Raised: $1,600,000
Coapt Systems

Palo Alto, California, United States

Coapt Systems develops bio-absorbable implants for use in soft tissue fixation during facial cosmetic surgery procedures.

BiotechnologyCosmetic SurgeryManufacturingMarketing
Debt FinancingDec 29, 2009
Amount Raised: $3,720,000
InteKrin

Los Altos, California, United States

InteKrin Therapeutics is focused on developing and commercializing therapeutics for neuroendocrine, metabolic and immune disorders.

BiotechnologyNeuroscienceTherapeutics
Series CAug 4, 2008
Amount Raised: $18,500,000
Novalar Pharmaceuticals

San Diego, California, United States

Novalar Pharmaceuticals develops oral pharmaceutical products, focusing on dental products such as OraVerse.

BiotechnologyDentalHealth CareMedical
Series DNov 2, 2007
Amount Raised: $30,000,000